Pharmacotherapeutic group: Antispasmodics; ATC code: A03BB01
Buscopan has a spasmolytic effect on the smooth muscle of the gastrointestinal, urogenital, and biliary tract. Hyoscine butylbromide is a quaternary ammonium derivative that does not cross into the central nervous system. Therefore, central anticholinergic adverse effects do not occur. Its peripheral anticholinergic effect results from ganglionic blockade in the visceral wall and antimuscarinic activity.
⚠️ Warnings
In cases of severe unexplained abdominal pain that persists or worsens, or is accompanied by symptoms such as fever, nausea, vomiting, changes in bowel movements, abdominal tenderness, decreased blood pressure, fainting, or blood in the stool, the cause of the symptoms must be investigated immediately.
Due to the potential risk of anticholinergic adverse effects, caution is required when administering the product to patients with a predisposition to or untreated narrow-angle glaucoma, patients at risk of intestinal or urinary tract obstruction, and patients prone to tachyarrhythmias.
Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase-isomaltase insufficiency should not take this medicinal product.
